Compass Group (CMPGY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Adial Pharmaceuticals (ADIL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Risk assessment plays a central role in the primary prevention of cardiovascular disease. The 2017 High Blood Pressure Clinical Practice Guideline incorporated quantitative risk assessment for the ...

Investors watch Walmart earnings as tariff policy, labor data, and retail sales shape outlook. Margins and Walmart Connect growth stay in focus after recent declines in profitability. Stock trades ...

Effective January 1, 2026, Nigeria will implement a significant new Personal Income Tax (PIT) reform. This change will affect the monthly take-home pay for millions of salaried workers across the ...

TORONTO - Rogers Communications Inc. (TSX:RCI.A and RCI.B; NYSE:RCI), the $19 billion telecommunications giant, announced Thursday it has reached a definitive agreement to sell its portfolio of nine ...

Abstract: The Envelope Correlation Coefficient (ECC) is a critical parameter in evaluating the performance of multiple sensors systems, particularly in wireless communication, sensing, and microwave ...